國立虎尾科技大學 |

Translational Research in Muscular Dystrophy

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Translational Research in Muscular Dystrophy/ edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura.
other author:	Takeda, Shin'ichi.
Description:	VIII, 199 p. 35 illus., 22 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Neurology . -
Online resource:	https://doi.org/10.1007/978-4-431-55678-7
ISBN:	9784431556787

Translational Research in Muscular Dystrophy
Translational Research in Muscular Dystrophy[electronic resource] /edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura. - 1st ed. 2016. - VIII, 199 p. 35 illus., 22 illus. in color.online resource.

1. Fukuyama congenital muscular dystrophy - Clinical aspects -- 2. α-Dystroglycanopathy -- 3. Myotonic dystrophy -- 4. Molecular pathogenesis and therapeutic strategy in GNE myopathy -- 5. Targeting the type I TGF-β receptor for treating caveolin-3-deficient autosomal dominant limb-girdle muscular dystrophy type 1C and muscle wasting disorders -- 6. Translational Research in Nucleic Acid Therapies for Muscular Dystrophies -- 7. Toward regenerative medicine for muscular dystrophies-Lessons from regeneration processes- -- 8. Stem cell-based therapy for Duchenne muscular dystrophy -- 9. Therapeutic approach of iPS cell technology for treating muscular dystrophy -- 10. Clinical aspects of GNE myopathy and translational medicine -- 11. Patient registries for international harmonized clinical development -- 12. Muscular Dystrophy Clinical Trial Network in Japan -- 13. Translational research on DMD in Japan From mice to exploratory investigator–initiated clinical trial in humans. .

This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies. It also describes the current systems for clinical trials and MD patient databases, resources, which will support the early realization of clinical application and improve patients’ quality of life. MD is the one of the most widely known inherited neuromuscular diseases and is classified into diverse types by symptoms, age of onset, mode of inheritance, and clinical progression. With the development of molecular biology, the occurrence mechanisms of each type of MD are gradually being elucidated. Although there is no known permanent cure yet, the stage of treatment research has now advanced to clinical trials.

ISBN: 9784431556787

Standard No.: 10.1007/978-4-431-55678-7doiSubjects--Topical Terms:

1253459
Neurology .

LC Class. No.: RC346-429.2

Dewey Class. No.: 616.8

Translational Research in Muscular Dystrophy
LDR:03225nam a22003975i 4500 001 975195
003 DE-He213
005 20200703193606.0
007 cr nn 008mamaa
008 201211s2016 ja | s |||| 0|eng d
020 $a 9784431556787 $9 978-4-431-55678-7
024 7 $a 10.1007/978-4-431-55678-7 $2 doi
035 $a 978-4-431-55678-7
050 4 $a RC346-429.2
072 7 $a MJN $2 bicssc
072 7 $a MED056000 $2 bisacsh
072 7 $a MKJ $2 thema
082 0 4 $a 616.8 $2 23
245 1 0 $a Translational Research in Muscular Dystrophy $h [electronic resource] / $c edited by Shin'ichi Takeda, Yuko Miyagoe-Suzuki, Madoka Mori-Yoshimura.
250 $a 1st ed. 2016.
264 1 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2016.
300 $a VIII, 199 p. 35 illus., 22 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a 1. Fukuyama congenital muscular dystrophy - Clinical aspects -- 2. α-Dystroglycanopathy -- 3. Myotonic dystrophy -- 4. Molecular pathogenesis and therapeutic strategy in GNE myopathy -- 5. Targeting the type I TGF-β receptor for treating caveolin-3-deficient autosomal dominant limb-girdle muscular dystrophy type 1C and muscle wasting disorders -- 6. Translational Research in Nucleic Acid Therapies for Muscular Dystrophies -- 7. Toward regenerative medicine for muscular dystrophies-Lessons from regeneration processes- -- 8. Stem cell-based therapy for Duchenne muscular dystrophy -- 9. Therapeutic approach of iPS cell technology for treating muscular dystrophy -- 10. Clinical aspects of GNE myopathy and translational medicine -- 11. Patient registries for international harmonized clinical development -- 12. Muscular Dystrophy Clinical Trial Network in Japan -- 13. Translational research on DMD in Japan From mice to exploratory investigator–initiated clinical trial in humans. .
520 $a This book presents recent advances in translational research on muscular dystrophy (MD) to physicians and researchers, including cutting-edge research on the disease such as regenerative medicine, next-generation DNA sequencing, and nucleic acid therapies. It also describes the current systems for clinical trials and MD patient databases, resources, which will support the early realization of clinical application and improve patients’ quality of life. MD is the one of the most widely known inherited neuromuscular diseases and is classified into diverse types by symptoms, age of onset, mode of inheritance, and clinical progression. With the development of molecular biology, the occurrence mechanisms of each type of MD are gradually being elucidated. Although there is no known permanent cure yet, the stage of treatment research has now advanced to clinical trials.
650 0 $a Neurology . $3 1253459
650 0 $a Molecular biology. $3 583443
650 0 $a Gene therapy. $3 582271
650 1 4 $a Neurology. $3 593894
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Gene Therapy. $3 580629
700 1 $a Takeda, Shin'ichi. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106242
700 1 $a Miyagoe-Suzuki, Yuko. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106243
700 1 $a Mori-Yoshimura, Madoka. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1106244
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9784431556770
776 0 8 $i Printed edition: $z 9784431556794
776 0 8 $i Printed edition: $z 9784431566748
856 4 0 $u https://doi.org/10.1007/978-4-431-55678-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)